RBC Capital Starts Teladoc (TDOC) at Outperform

RBC Capital analyst Sean Dodge initiates coverage on Teladoc (NYSE: TDOC) with an Outperform rating and a price target of $100.00.

The analyst commented, "Telehealth is approaching its tipping point; we expect utilization to grow significantly over the coming years. TDOC is the market leader with durable competitive advantages, and therefore, best positioned to capitalize on the opportunity. The combination of new member adds, cross-selling and ramping utilization should drive ~25% organic revenue growth over the next 3+ years."

For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.

Shares of Teladoc closed at $77.45 yesterday.

You May Also Be Interested In

• Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
• GLJ Research Upgrades Cleveland-Cliffs (CLF) to Buy
• Intel (INTC) PT Lowered to $125 at Cantor Fitzgerald on Cloudy Picture for Client, Share Losses